-
-
-
-
-
-
-
Sun Pharma to buy US drugmaker Organon for $11.75 billion in India's largest pharma deal
-
-
-
-
-
-
-
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025
-
-
-
-
-
-
-
ORGANON SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Organon & Co. - OGN
-
-
-
-
-
-
-
ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Or
-
-
-
-
-
-
-
OGN INVESTOR NOTICE: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
-
-
-
-
-
-
-
OGN INVESTOR DEADLINE: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
-
-
-
-
-
-
-
Shareholders who lost money on Organon & Co. (NYSE: OGN). Should Contact Wolf Haldenstein
-
1,232,680 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


